Brought to you by 
Sinclair Pharma closes £8.9mm IPO
21 Dec 2003
Executive Summary
Niche market pharmaceutical developer Sinclair Pharma PLC (specializing in dermatology, oral health, and oncology) has completed its IPO on the London Stock Exchange's AIM, netting £8.9mm ($15.4mm) through the sale of 9.4mm ordinary shares at 115p apiece. Selling stockholders placed an additional 9.6mm shares.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com